Positions
Research work
Performance
Performance
2023
2022
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Functionality of a bicistronic construction containing HEXA and HEXB genes encoding ?-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses//Neural Regeneration Research. - 2022. - Vol.17, Is.1. - P.122-129.
-
Chulpanova D.S, Shaimardanova A.A, Ponomarev A.S, Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis//International Journal of Molecular Sciences. - 2022. - Vol.23, Is.5. - Art. №2506.
-
Chulpanova D.S, Tazetdinova L.G, Arkhipova S.S, In Vivo Visualization of Stable Neuroblastoma Cell Lines with Overexpression of Firefly Luciferase or Far-Red Fluorescent Protein//BioNanoScience. - 2022. - Vol., Is.. - .
- Препарат для лечения метахроматической лейкодистрофии / А.И. Муллагулова, А.А. Шаймарданова, Д.С. Чулпанова, В.В. Соловьева, Я.О. Мухамедшина, А.А. Костенников, А.А. Ризванов // Заявке на изобретение № 2021115696/10(033131). Дата приоритета: 01.06.2021
-
Tay-Sachs disease and Sandhoff disease are severe hereditary neurodegenerative disorders caused by a deficiency of β-hexosaminidase A (HexA) enzyme, which results in the accumulation of GM2 gangliosides in the nervous system cells. In this work, we analyzed the efficacy and safety of cell-mediated gene therapy for Sandhoff disease and Sandhoff disease using a bicistronic lentiviral vector encoding cDNA of HexA α- and β-subunit genes separated by the nucleotide sequence of a P2A peptide (HEXA-HEXB). The functionality of the bicistronic construct containing the HEXA-HEXB genetic cassette was analyzed in a culture of HEK293T cells and human umbilical cord blood mononuclear cells (hUCBMCs). Our results showed that the enzymatic activity of HexA in the conditioned medium harvested from genetically modified HEK293T-HEXA-HEXB and hUCBMCs-HEXA-HEXB was increased by 23 and 8 times, respectively, compared with the conditioned medium of native cells. Western blot analysis showed that hUCBMCs-HEXA
NRR_17_122.pdf - Gilazieva Z , Chulpanova D , Ponomarev A , Comparative Analysis of Natural and Cytochalasin B-Induced Membrane Vesicles from Tumor Cells and Mesenchymal Stem Cells//CURRENT ISSUES IN MOLECULAR BIOLOGY. - 2022. - Vol.44, Is.11. - P.5363-5378.
- Filin I, Kitaeva K, Chulpanova D, Analysis of immune cell activation after interaction with membrane vesicles from genetically modified tumor cells//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Shaimardanova A, Chulpanova D, Issa S, Cross-correction of beta-hexosaminidase a deficiency using genetically modified human mesenchymal stem cells in a cell culture of tay-sachs disease patient//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Chulpanova D, Pukhalskaia T, Rizvanov A, Cytochalasin B-induced membrane vesicles from mesenchymal stem cells overexpressing TRAIL activate key components of the apoptotic pathway in breast cancer mouse model//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Shaimardanova AA, Chulpanova DS, Solovyeva VV, Functionality of a bicistronic construction containing HEXA and HEXB genes encoding beta-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses//NEURAL REGENERATION RESEARCH. - 2022. - Vol.17, Is.1. - P.122-129.
- Shaimardanova A. Generation and functional analysis of plasmid DNA encoding beta-hexosaminidase gene for Tay-Sachs disease therapy / A. Shaimardanova, D. Chulpanova, V. Solovyeva, A. Rizvanov // HUMAN GENE THERAPY. – 2019. – Vol. 30(11), P. A155-A156 (Impact Factor = 4,51). Q1
-
Chulpanova D.S, Pukhalskaia T.V, Rizvanov A.A, Contribution of Tumor-Derived Extracellular Vesicles to Malignant Transformation of Normal Cells//Bioengineering. - 2022. - Vol.9, Is.6. - Art. №245.
2021
-
Chulpanova D.S, Gilazieva Z.E, Kletukhina S.K, Cytochalasin B-Induced membrane vesicles from human mesenchymal stem cells overexpressing IL2 are able to stimulate CD8+ T-Killers to kill human triple negative breast cancer cells//Biology. - 2021. - Vol.10, Is.2. - P.1-32.
-
Lo Sasso G, Khachatryan L, Kondylis A, Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients//Inflammatory bowel diseases. - 2021. - Vol.27, Is.3. - P.418-433.
- Shaimardanova A., Chulpanova D., Solovyeva V., Development and analysis of genetically modified mesenchymal stem cells with overexpression of HEXA and HEXB genes for the therapy of Tay-Sachs disease//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2021. - Vol.51, Is.. - P.50-51.
- Shaimardanova A., Chulpanova D., Solovyeva V., Development of an AAV9-based gene drug and the method of treatment for metachromatic leukodystrophy//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2021. - Vol.51, Is.. - P.51-52.
-
Chulpanova D.S, Gilazieva Z.E, Akhmetzyanova E.R, Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-b1 can kill carcinoma cancer cells//Tissue and Cell. - 2021. - Vol.73, Is.. - Art. №101664.
-
Способ терапии болезни Тея-Сакса и болезни Сандхоффа с помощью генетически модифицированных мезенхимных стволовых клеток человека со сверхэкспрессией β-гексозаминидазы A: Пат. 2748383 Российская Федерация, МПК A61K 35/28, A61K 48/00, A61P 3/00. Патентообладатель Казанский (Приволжский) федеральный университет. Авторы: А.А. Шаймарданова, Д.С. Чулпанова, В.В. Соловьева, А.А. Ризванов. Заявка на патент на изобретение № 2020134611/14(063518). Дата подачи заявки 21.10.2020; опубл. 25.05.2021.
Patent_2021.pdf - Shaimardanova AA, Chulpanova DS, Solovyeva VV, Development of cell-mediated gene therapy for Tay-Sachs disease//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A147-A147.
- Issa SS, Shaimardanova AA, Chulpanova DS, Development of cell-mediated gene therapy method for metachromatic leukodystrophy using modified mesenchymal stem cells//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A142-A142.
- Shaimardanova AA, Chulpanova DS, Solovyeva VV, Serum Cytokine Profile, Beta-Hexosaminidase A Enzymatic Activity and GM(2) Ganglioside Levels in the Plasma of a Tay-Sachs Disease Patient after Cord Blood Cell Transplantation and Curcumin Administration: A Case Report//LIFE-BASEL. - 2021. - Vol.11, Is.10. - Art. №1007.
- Pukhalskaia TV, Chulpanova DS, Rizvanov AA, The influence of cytochalasin B-induced membrane vesicles derived from mesenchymal stem cells overexpressing TRAIL on the expression of apoptotic genes in triple-negative MDA-MB-231 breast cancer cells//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A143-A143.
- Kitaeva KV, Filin IY, Chulpanova DS, The proliferative activity and cytokine secretion changes in mesenchymal stem cell and neuroblastoma cells during co-culture under hypoxic conditions//HUMAN GENE THERAPY. - 2021. - Vol.32, Is.19-20. - P.A150-A151.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Serum cytokine profile, beta-hexosaminidase a enzymatic activity and gm2 ganglioside levels in the plasma of a tay-sachs disease patient after cord blood cell transplantation and curcumin administration: A case report//Life. - 2021. - Vol.11, Is.10. - Art. №1007.
2020
-
Shaimardanova A, Solovyeva V, Chulpanova D, Extracellular vesicles in the diagnosis and treatment of central nervous system diseases//Neural Regeneration Research. - 2020. - Vol.15, Is.4. - P.586-596.
- I.I. Abdrakhmanova, D.S. Chulpanova, V.M. Chernov, V.V. Solovyeva, E.Y. Zakirova, A.A. Rizvanov. Analysis of antitumor activity of canine mesenchymal stem cells expressing tumor suppressors and immunomodulator genes in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.84-84
-
Chulpanova D.S, Kitaeva K.V, Green A.R, Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy//Frontiers in Cell and Developmental Biology. - 2020. - Vol.8, Is.. - Art. № 402.
-
Chulpanova D.S, Kitaeva K.V, Rutland C.S, Mouse tumor models for advanced cancer immunotherapy//International Journal of Molecular Sciences. - 2020. - Vol.21, Is.11. - P.1-15.
-
Chulpanova D.S, Solovyeva V.V, Isaeva G.S, Recombinant histone H1.3 inhibits orthohantavirus infection in vitro//BioNanoScience. - 2020. - Vol., Is.. - .
-
Solovyeva V.V, Shaimardanova A.A, Chulpanova D.S, Tay-Sachs disease: Diagnostic, modeling and treatment approaches//Genes and Cells. - 2020. - Vol.15, Is.1. - P.17-22.
-
Chulpanova D.S, Solovyeva V.V, James V, Human mesenchymal stem cells overexpressing interleukin 2 can suppress proliferation of neuroblastoma cells in co-culture and activate mononuclear cells in vitro//Bioengineering. - 2020. - Vol.7, Is.2. - P.1-27.
- Filin I., Kitaeva K., Chulpanova D., Analysis of the interaction of colon carcinoma cell-derived extracellular vesicles and human T-cells in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.88-89.
- Kitaeva K., Chulpanova D., Filin I., Apoptotic gene mRNA expression in mesenchymal stromal cells and neuroblastoma cells after co-culturing and cisplatin treatment//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.83-83.
- Gilazieva Z., Ponomarev A., Zhuravleva M., The effect of mesenchymal stem cell derived extracellular vesicles on tumor spheroids in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.82-82.
- Shaimardanova A., Chulpanova D., Solovyeva V., Production and functional analysis of a recombinant genetic construct that simultaneously encodes beta-hexosaminidase A alpha-and beta-subunit genes//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.87-88.
- Shaimardanova A., Chulpanova D., Solovyeva V., The effect of cord blood cell transplantation and curcumin administration on plasma HexA activity and serum cytokine profile in Tay-Sachs disease patient//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.40-41.
- Chulpanova D., Solovyeva V., Rizvanov A., The effect of mesenchymal stem cells with overexpression of cytokines on the viability of human melanoma//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.81-81.
- Chulpanova D., Shaimardanova A., Tazetdinova L., Immunomodulating properties of mesenchymal stem cells with simultaneous overexpression of TRAIL, PTEN and IFN beta 1//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.88-88.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches//Frontiers in Medicine. - 2020. - Vol.7, Is.. - Art. № 576221.
- Abdrakhmanova I., Chulpanova D., Shaimardanova A., Analysis of antitumor activity of canine mesenchymal stem cells expressing tumor suppressors and immunomodulator genes in vitro//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.84-84.
- Chulpanova D., Rizvanov A., Solovyeva V., Analysis of the antitumor activity of extracellular vesicles isolated from mesenchymal stem cells with overexpression of cytokines and tumor suppressors//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2020. - Vol.50, Is.. - P.81-82.
-
Shaimardanova A.A, Chulpanova D.S, Solovyeva V.V, New therapeutic strategies for the treatment of metachromatic leukodystrophy//Genes and Cells. - 2020. - Vol.15, Is.2. - P.41-50.
-
Chulpanova D.S, Shaimardanova A.A, Solovyeva V.V, iPSCs for modeling lysosomal storage diseases//Recent Advances in iPSC Disease Modeling. - 2020. - Vol., Is.. - P.1-28.
-
Chulpanova, D. S., Solovyeva, V. V., James, V., Arkhipova, S. S., Gomzikova, M. O., Garanina, E. E., Akhmetzyanova, E.R., Tazetdinova, L.G., Khaiboullina, S.F. & Rizvanov, A. A. (2020). Human mesenchymal stem cells overexpressing interleukin 2 can suppress proliferation of neuroblastoma cells in co-culture and activate mononuclear cells in vitro. Bioengineering, 7(2), 59.
bioengineering_07_00059.pdf -
Генетическая кассета, содержащая кодон - оптимизированные нуклеотидные последовательности генов HEXA и HEXВ, и фармацевтическая композиция для лечения болезни Тея - Сакса: Пат. 2723187 Российская Федерация, МПК C 12 N 9/24, C 12 N 15/63, C 12 N 15/85, A 61 K 38/47, A 61 K 48/00, A 61 P 25/28 / А. А. Шаймарданова, Д. С. Чулпанова, В. В. Соловьева, А. А. Ризванов; заявитель и патентообладатель Казан. федер. ун-т. - № 2019131306 ; заявл. 04.10.2019 ; опубл. 09.06.2020, Бюл. № 16.
F_Patent_geneticheskaya_kasseta_BTS.pdf
2019
- Garanina Ekaterina, Chulpanova Daria, Solovyeva Valeriya, Multiplex analysis of conditioned medium of mesenchymal stem cells with IL2 overexpression//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2019. - Vol.49, Is.. - P.162-163.
- Филин И.Ю., Китаева К.В., Чулпанова Д.С., Ризванов А.А., Соловьева В.В. Анализ взаимодействия внеклеточных везикул клеток карциномы толстой кишки с Т-лимфоцитами человека in vitro / И.Ю. Филин, К.В. Китаева, Д.С. Чулпанова, А.А. Ризванов, В.В. Соловьева // Материалы IV Национального конгресса по регенеративной медицине. Гены и клетки. - Москва. - 2019. - Том XIV, Приложение. - С. 243.
- Rizvanov Albert, Kitaeva Kristina, Chulpanova Daria, The effect of intercellular interaction of MSC and SH-SY5Y in co-culture on result of cisplatin treatment//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2019. - Vol.49, Is.. - P.166-166.
-
Solovyeva V.V, Chulpanova D.S, Tazetdinova L.G, In Vitro Angiogenic Properties of Plasmid DNA Encoding SDF-1? and VEGF165 Genes//Applied Biochemistry and Biotechnology. - 2019. - Vol., Is.. - .
-
Shaimardanova A.A, Kitaeva K.V, Abdrakhmanova I.I, Production and application of multicistronic constructs for various human disease therapies//Pharmaceutics. - 2019. - Vol.11, Is.11. - Art. № 580.
- Tazetdinova L. G., Chulpanova D. S., Fazleeva I. I., Production of mouse mesenchymal stem cell lines with Luciferase and Katushka2s reporter gene expression for bioluminescence imaging//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A64-A64.
- Kitaeva K. V., Chulpanova D. S., Prudnikov T. S., The effect of co-culturing of MSC and SH-SY5Y and cisplatin treatment on proliferative activity and caveolin-1 mRNA expression//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A62-A62.
- Tazetdinova L., Arkhipova S., Baranova V., An immunocompetent mouse model of human neuroblastoma//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A58-A58.
- Kitaeva K. V., Chulpanova D. S., Prudnikov T. S., Analysis of Rac1, Bcl2, Cav1 alpha, and Cav1 beta gene expression of neuroblastoma cells, mesenchymal stem cells and human peripheral blood mononuclear cells after co-cultivation//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A66-A66.
- Chulpanova D. S., Kletukhina S. K., Rizvanov A. A., Antitumor properties of artificial microvesicles from mesenchymal stem cells overexpressing TNF-related apoptosis inducing ligand//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A63-A63.
- Shaimardanova A. A., Chulpanova D. S., Solovyeva V. V., Generation and functional analysis of plasmid DNA encoding beta-hexosaminidase gene for Tay-Sachs disease therapy//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A155-A156.
- Старостина И.Г. MyoD-индуцированная трансдифференцировка дермальных фибробластов с мутацией в гене DYSF, рассматриваемая как тест-система для скрининга препаратов дисферлинопатии / И. Г. Старостина, Д.С. Чулпанова, А.А. Шаймарданова, В.В. Соловьева, И.А. Яковлев, Р.В. Деев, А.А. Исаев, А.А. Ризванов // Научно-практический журнал «Гены и Клетки«, материалы IV Национального конгресса по регенеративной медицине. - 2019. - Том XIV, Приложение, 2019. - С.220-221.
- Яковлев И.А. Применение CRISPR-опосредованной транскрипционной активации с целью создания клеточных тест-систем для разработки и проверки методов генной терапии наследственных заболеваний мышечной ткани / И.А. Яковлев, И. Г. Старостина, Д.С. Чулпанова, А.А. Шаймарданова, В.В. Соловьева, А.А. Ризванов, Р.В. Деев, А.А. Исаев // Научно-практический журнал «Гены и Клетки«, материалы IV Национального конгресса по регенеративной медицине. - 2019. - Том XIV, Приложение, 2019. - С.270.
- Тазетдинова Л.Г., Чулпанова Д.С., Фазлеева И.И., Филин И.Ю., Соловьева В.В., Ризванов А.А. Анализ противоопухолевой активности мезенхимных стволовых клеток, загруженных препаратом цисплатин, в культуре клеток нейробластомы in vitro / Л.Г. Тазетдинова, Д.С. Чулпанова, И.И. Фазлеева, И.Ю. Филин, В.В. Соловьева, А.А. Ризванов // Актуальные проблемы нейробиологии – Казань – 2019 – С. 79 – 80
- Tazetdinova L., Arkhipova S., Baranova V., Abdrakhmanova I., Filin I., Mullagulova A., Chulpanova D., Solovyeva V., Rizvanov A. An immunocompetent mouse model of human neuroblastoma / L. Tazetdinova, S. Arkhipova, V. Baranova, I. Abdrakhmanova, I. Filin, A. Mullagulova, D. Chulpanova, V. Solovyeva, A. Rizvanov // HUMAN GENE THERAPY. - 2019. - Vol. 30, Is. 11. - P. A58-A58.
- Tazetdinova L.G., Chulpanova D.S., Fazleeva I.I., Filin I.Y., Mullagulova A.I., Solovyeva V.V., Rizvanov A.A. Production of mouse mesenchymal stem cell lines with Luciferase and Katushka2s reporter gene expression for bioluminescence imaging / L.G. Tazetdinova, D.S. Chulpanova, I.I. Fazleeva, I.Y. Filin, A.I. Mullagulova, V.V. Solovyeva, A.A. Rizvanov // HUMAN GENE THERAPY. - 2019. - Vol. 30, Is. 11. - P. A64-A64.
- Rizvanov Albert, Chulpanova Daria, Solovyeva Valeriya, Preparation and analysis of artificial extracellular vesicles from mesenchymal stem cells overexpressing TRAIL, PTEN or IFNA17//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2019. - Vol.49, Is.. - P.166-166.
2018
-
Chulpanova D.S, Kitaeva K.V, Tazetdinova L.G, Application of Mesenchymal stem cells for therapeutic agent delivery in anti-tumor treatment//Frontiers in Pharmacology. - 2018. - Vol.9, Is.MAR. - Art. № 259.
- Chulpanova D. S., Arkhipova S. S., Solovyeva V. V., The effect of interleukin 2 overexpression on the ultrastructure of human mesenchymal stem cells.//MOLECULAR BIOLOGY OF THE CELL. - 2018. - Vol.29, Is.26. - .
- Chulpanova D., Solovyeva V., Tazetdinova L., Generation and analysis of mesenchymal stem cell line stably expressing IL2//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.87-87.
- Chulpanova Daria S., Kitaeva Kristina V., James Victoria, Therapeutic Prospects of extracellular vesicles in Cancer Treatment//FRONTIERS IN IMMUNOLOGY. - 2018. - Vol.9, Is.. - Art. №1534.
- Tazetdinova L., Gilazieva Z., Arkhipova S., Viability and ultrastructure of human mesenchymal stem cells primed with cisplatin//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.87-87.
-
Front. Physiol. ? 2018.
- Chulpanova D.S. Production and analysis of stable mesenchymal stem cell culture with IL-2 overexpression / D.S. Chulpanova, V.V. Solovyeva, L.G. Tazetdinova, S.K. Kletukhina, A.A. Rizvanov // Abstract book «Kazan precision medicine workshop», Kazan. - September 10-12, 2018. – P.13
-
Solovyeva V.V, Shaimardanova A.A, Chulpanova D.S, New approaches to Tay-Sachs disease therapy//Frontiers in Physiology. - 2018. - Vol.9, Is.NOV. - Art. № 1663.
-
Chulpanova D.S, Solovyeva V.V, Kitaeva K.V, Recombinant viruses for cancer therapy//Biomedicines. - 2018. - Vol.6, Is.4. - Art. № 94.
- Solovyeva V. V., Kitaeva K. V., Chulpanova D. S., Analysis of the interaction of mesenchymal stem cells with artificial human neuroblastoma cell-derived microvesicles using imaging flow cytometry//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A70-A70.
- Tazetdinova L. G., Chulpanova D. S., Gilazieva Z. E., Effect of genetic modification with reporter genes on mesenchymal stem cell differential ability into osteogenic, adipogenic and chondrogenic lineages//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A78-A79.
- Chulpanova D. S., Solovyeva V. V., Zakirova E. Yu, Generation of genetically engineered canine mesenchymal stem cells co-expressing immunomodulating cytokines and tumour suppressors//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A52-A53.
- Chulpanova D. S., Solovyeva V. V., Tazetdinova L. G., IL-2 genetically modified mesenchymal stem cells demonstrate increased VEGF, MMP2 and TGF-beta 1 genes expression//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A55-A55.
- Chulpanova D. S., Shaimardanova A. A., Solovyeva V. V., MyoD-directed reprogramming of fibroblasts with DYSF gene mutation for human dysferlinopathy modeling//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A98-A98.
- Kitaeva K. V., Prudnikov T. S., Chulpanova D. S., Rac1 and Bcl-2 expression changes in co-culture of mesenchymal stem cells and neuroblastoma cells after incubation with cisplatin//HUMAN GENE THERAPY. - 2018. - Vol.29, Is.12. - P.A54-A55.
- Chulpanova Daria, Soloveva Valeriya, Tazetdinova Leisan G., Analysis of the Effect of Mesenchymal Stem Cells Culture with Interleukin 2 Overexpression on Human Mononuclear Cells Activation in Vitro//BLOOD. - 2018. - Vol.132, Is.. - .
- Chulpanova D.S. MyoD-directed reprogramming of fibroblasts with DYSF gene mutation for human dysferlinopathy modeling / D.S. Chulpanova, A.A. Shaimardanova, V. V. Solovyeva, I. G. Starostina, I. A. Yakovlev, R. V. Deev, A. A. Isaev, A .A. Rizvanov // HUMAN GENE THERAPY ? 27: A2?A169. ? P. A98 - 2018.
- Kitaeva K. K., Prudnikov T. S., Chulpanova D. S., Cav1a and Cav1b expression changes in co-culture of mesenchymal stem cells and neuroblastoma cells after incubation with cisplatin.//MOLECULAR BIOLOGY OF THE CELL. - 2018. - Vol.29, Is.26. - .
- Tazetdinova L., Gilazieva Z., Arkhipova S., Effect of paclitaxel on ultrastructure of adipose-derived mesenchymal stem cells//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.104-105.
2017
| Work address: | 9 Parizhskoy Kommuny Str., Kazan, Academic and Research Centre of the Institute of Fundamental Medicine and Biology |
| Office number: | 328 |
| E-mail: | DaSChulpanova@kpfu.ru |
| Google scholar: | https://scholar.google.ru/citations?user=hWQJPfUAAAAJ&hl=ru |